Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 8
1997 4
1998 4
1999 4
2000 3
2002 1
2003 4
2004 8
2005 5
2006 6
2007 9
2008 10
2009 8
2010 14
2011 26
2012 17
2013 9
2014 12
2015 14
2016 19
2017 20
2018 25
2019 25
2020 23
2021 25
2022 21
2023 21
2024 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

310 results

Results by year

Filters applied: . Clear all
Page 1
Denosumab Discontinuation.
Sølling AS, Tsourdi E, Harsløf T, Langdahl BL. Sølling AS, et al. Among authors: langdahl bl. Curr Osteoporos Rep. 2023 Feb;21(1):95-103. doi: 10.1007/s11914-022-00771-6. Epub 2022 Dec 24. Curr Osteoporos Rep. 2023. PMID: 36564572 Review.
Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials.
Händel MN, Cardoso I, von Bülow C, Rohde JF, Ussing A, Nielsen SM, Christensen R, Body JJ, Brandi ML, Diez-Perez A, Hadji P, Javaid MK, Lems WF, Nogues X, Roux C, Minisola S, Kurth A, Thomas T, Prieto-Alhambra D, Ferrari SL, Langdahl B, Abrahamsen B. Händel MN, et al. Among authors: langdahl b. BMJ. 2023 May 2;381:e068033. doi: 10.1136/bmj-2021-068033. BMJ. 2023. PMID: 37130601 Free PMC article.
Treatment Sequence for Osteoporosis.
Cosman F, Langdahl B, Leder BZ. Cosman F, et al. Among authors: langdahl b. Endocr Pract. 2024 May;30(5):490-496. doi: 10.1016/j.eprac.2024.01.014. Epub 2024 Feb 2. Endocr Pract. 2024. PMID: 38311211 Review.
Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus.
Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O'Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts NB, Brandi ML, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, Al Dabagh R, Davison KS, Kendler DL, Sándor GK, Josse RG, Bhandari M, El Rabbany M, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston J; International Task Force on Osteonecrosis of the Jaw. Khan AA, et al. Among authors: langdahl bl. J Bone Miner Res. 2015 Jan;30(1):3-23. doi: 10.1002/jbmr.2405. J Bone Miner Res. 2015. PMID: 25414052 Free article. Review.
Overview of treatment approaches to osteoporosis.
Langdahl BL. Langdahl BL. Br J Pharmacol. 2021 May;178(9):1891-1906. doi: 10.1111/bph.15024. Epub 2020 Mar 20. Br J Pharmacol. 2021. PMID: 32060897 Free article. Review.
Postmenopausal osteoporosis.
Eastell R, O'Neill TW, Hofbauer LC, Langdahl B, Reid IR, Gold DT, Cummings SR. Eastell R, et al. Among authors: langdahl b. Nat Rev Dis Primers. 2016 Sep 29;2:16069. doi: 10.1038/nrdp.2016.69. Nat Rev Dis Primers. 2016. PMID: 27681935 Review.
Goal-directed osteoporosis treatment: ASBMR/BHOF task force position statement 2024.
Cosman F, Lewiecki EM, Eastell R, Ebeling PR, Jan De Beur S, Langdahl B, Rhee Y, Fuleihan GE, Kiel DP, Schousboe JT, Borges JL, Cheung AM, Diez-Perez A, Hadji P, Tanaka S, Thomasius F, Xia W, Cummings SR. Cosman F, et al. Among authors: langdahl b. J Bone Miner Res. 2024 Sep 26;39(10):1393-1405. doi: 10.1093/jbmr/zjae119. J Bone Miner Res. 2024. PMID: 39073912 Free PMC article.
Romosozumab in postmenopausal women with low bone mineral density.
McClung MR, Grauer A, Boonen S, Bolognese MA, Brown JP, Diez-Perez A, Langdahl BL, Reginster JY, Zanchetta JR, Wasserman SM, Katz L, Maddox J, Yang YC, Libanati C, Bone HG. McClung MR, et al. Among authors: langdahl bl. N Engl J Med. 2014 Jan 30;370(5):412-20. doi: 10.1056/NEJMoa1305224. Epub 2014 Jan 1. N Engl J Med. 2014. PMID: 24382002 Free article. Clinical Trial.
Romosozumab and antiresorptive treatment: the importance of treatment sequence.
Cosman F, Kendler DL, Langdahl BL, Leder BZ, Lewiecki EM, Miyauchi A, Rojeski M, McDermott M, Oates MK, Milmont CE, Libanati C, Ferrari S. Cosman F, et al. Among authors: langdahl bl. Osteoporos Int. 2022 Jun;33(6):1243-1256. doi: 10.1007/s00198-021-06174-0. Epub 2022 Feb 15. Osteoporos Int. 2022. PMID: 35165774 Free PMC article.
Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS.
Tsourdi E, Zillikens MC, Meier C, Body JJ, Gonzalez Rodriguez E, Anastasilakis AD, Abrahamsen B, McCloskey E, Hofbauer LC, Guañabens N, Obermayer-Pietsch B, Ralston SH, Eastell R, Pepe J, Palermo A, Langdahl B. Tsourdi E, et al. Among authors: langdahl b. J Clin Endocrinol Metab. 2020 Oct 26:dgaa756. doi: 10.1210/clinem/dgaa756. Online ahead of print. J Clin Endocrinol Metab. 2020. PMID: 33103722
310 results